EUVIMEDEUVIMED entdecken
Crossref

Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, Toru Maekawa, D. Sakthi Kumar

NanoWorld Journal · 2015

DOI: 10.17756/nwj.2015-005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NanoWorld Journal, 2015. Verfasst von Archana Raichur und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field.However the research in this field is still in its infancy.Many challenges like safe delivery of targeted siRNA to nucleus and cytosol of cancerous cells without compromising the activity of siRNA needs to be addressed.We have overcome this hurdle with the help of nanotechnology using PLGA hollow nanoparticles (PLGAHNPs) and suppressing the oncogene of MYC transcription factors by using anti myc-siRNAs in human cancer cell lines.siRNA was encapsulated in PLGAHNPs.These spherical PLGAHNPs of size 70 nm had high efficiency of gene release at pH 4.2 under in vitro conditions.Cell penetrating peptide (CPP)-Tat peptide (TAT) and peptide nucleic acidnucleolus localizing signal (PNA-NLS) was used for siRNA delivery without affecting the therapeutic activity of siRNA.The siRNA duplex was prepared using T7 polymerase and double stranded DNA through in vitro transcription.Incubation of the siRNA encapsulated PLGAHNPs functionalized with TAT and PNA-NLS (TAT-siRNA-PNA-PLGAHNPs-siRNA) with cancer cells resulted in reduced cell proliferation.A downregulation of gene expression by 90% was observed even with low concentration of siRNA.We found complete arrest of cell division which was mediated by downregulation of MYC expression.

Zitieren

APA

Raichur, A., Nakajima, Y., Nagaoka, Y., Matsumoto, K., Mizuki, T., Kato, K., Maekawa, T., & Kumar, D. S. (2015). Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal. https://doi.org/10.17756/nwj.2015-005

Vancouver

Raichur A, Nakajima Y, Nagaoka Y, Matsumoto K, Mizuki T, Kato K, et al. Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal. 2015. doi:10.17756/nwj.2015-005

BibTeX
@article{Raichur2015,
  author = {Raichur, Archana and Nakajima, Yoshikata and Nagaoka, Yutaka and Matsumoto, Kotaro and Mizuki, Toru and Kato, Kazunori and Maekawa, Toru and Kumar, D. Sakthi},
  title = {Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA},
  journal = {NanoWorld Journal},
  year = {2015},
  doi = {10.17756/nwj.2015-005}
}
Kostenlos starten →